Showing results (41-50 of 352) with videos related to
Sort By:
Pageof 36
Clinical Pharmacology and Therapeutics|September 9, 2011
From treating complex coronary artery disease to promoting cardiovascular health: therapeutic transitions and challenges, 2010-2020J C Kovacic, V FusterHuman Biology|June 30, 2004
Socioeconomic, demographic, and geographic variables affecting the diverse degrees of consanguineous marriages in SpainV Fuster, S E ColantonioJournal of the American College of Cardiology|December 1, 1986
Pharmacology of platelet inhibitorsL A Harker, V FusterLa Ricerca in Clinica E in Laboratorio|October 1, 1979
Von Willebrand's disease in pigs and atherosclerosisV Fuster, E J BowieThrombosis and Haemostasis|April 30, 1978
The von Willebrand pig as a model for atherosclerosis researchV Fuster, E J BowieMayo Clinic Proceedings|March 1, 1981
10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts)V Fuster, J H ChesebroMayo Clinic Proceedings|February 1, 1981
Antithrombotic therapy: role of platelet-inhibitor drugs. I. Current concepts of thrombogenesis: role of platelets. (first of three parts)V Fuster, J H ChesebroProgress in Cardiovascular Diseases|December 24, 1997
Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac diseaseA E Schussheim, V FusterThe Mount Sinai Journal of Medicine, New York|September 1, 1995
The three mechanisms for coronary artery disease progression: insights into future managementM A McLaughlin, V FusterPageof 36